Atorvastatin impurity C - Names and Identifiers
Atorvastatin impurity C - Physico-chemical Properties
Molecular Formula | C66H68CaF2N4O10
|
Molar Mass | 1155.3417264 |
Melting Point | >141°C (dec.) |
Solubility | DMSO (Slightly, Heated, Sonicated), Methanol (Slightly) |
Appearance | neat |
Color | White to Off-White |
Storage Condition | Hygroscopic, -20°C Freezer, Under inert atmosphere |
Stability | Hygroscopic |
Use | Inspection |
Atorvastatin impurity C - Risk and Safety
Atorvastatin impurity C - Introduction
Atorvastatin Calcium impurity III (Difluoro Atorvastatin Calcium Salt) is an important impurity of Atorvastatin Calcium, and its chemical structure has two fluorine atoms substituted for a certain position of Atorvastatin molecule. The following is a description of the properties, uses, preparation and safety information of Atorvastatin Calcium Impurity III:
Nature:
Atorvastatin Calcium Impurity III is a solid compound in the form of a white to off-white crystalline powder. It is stable at room temperature and can be dissolved in water, but its solubility is lower than that of atorvastatin calcium.
Use:
Atorvastatin Calcium Impurity III is generally present as an impurity of the atorvastatin drug substance. Its presence may have an impact on the purity and stability of the drug, so its presence needs to be strictly controlled during the pharmaceutical process. In addition, atorvastatin calcium impurity III is also commonly used to study and monitor the quality of atorvastatin drugs.
Preparation Method:
The preparation method of atorvastatin calcium impurity III can be carried out by chemical synthesis. The specific synthetic steps and conditions may vary depending on the research or pharmaceutical needs.
Safety Information:
There is limited information on the safety of atorvastatin calcium impurity III because most of the research and literature focuses on atorvastatin itself. However, based on the general safety profile of atorvastatin, relatively low toxicity of its impurities can be expected. However, in the pharmaceutical process, its presence needs to be closely monitored to ensure the quality and safety of the product.
Last Update:2024-04-09 21:54:55